Evidence map›Paper›PMID 36865234›Full record

ArticlebioRxiv : the preprint server for biology2023

Pacybara: Accurate long-read sequencing for barcoded mutagenized allelic libraries.

Jochen Weile, Gabrielle Ferra, Gabriel Boyle, Sriram Pendyala, Clara Amorosi, Chiann-Ling Yeh, Atina G Cote, Nishka Kishore, Daniel Tabet, Warren van Loggerenberg and 4 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Jochen WeileLunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, M5G 1X5, Canada.ORCID 0000-0003-1628-9390
Gabrielle FerraDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.
Gabriel BoyleDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.
Sriram PendyalaDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.
Clara AmorosiDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.
Chiann-Ling YehDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.ORCID 0000-0003-4032-8871
Atina G CoteLunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, M5G 1X5, Canada.
Nishka KishoreLunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, M5G 1X5, Canada.
Daniel TabetLunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, M5G 1X5, Canada.
Warren van LoggerenbergLunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, M5G 1X5, Canada.
Ashyad RayhanLunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, M5G 1X5, Canada.
Douglas M FowlerDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.
Maitreya J DunhamDepartment of Genome Sciences, University of Washington, Seattle, WA, USA.ORCID 0000-0001-9944-2666
Frederick P RothLunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, ON, M5G 1X5, Canada.ORCID 0000-0002-6628-649X
University of Washington · USUniversity of Toronto · CAUniversity of Pittsburgh · US

Funding

Technology to understand genetic variant effects in contextRM1HG010461 · NHGRI · UNIVERSITY OF WASHINGTON · PI Douglas M Fowler, Bruce Colston Trapnell · 2019 to 2026
$18.9M
The Center for Actionable Variant Analysis; measuring variant function at scaleUM1HG011969 · NHGRI · UNIVERSITY OF WASHINGTON · PI Douglas M Fowler, Lea Starita · 2021 to 2026
$9.9M
Molecular phenotyping of ~100,000 coding variants across Mendelian disease genesUM1HG011989 · NHGRI · DANA-FARBER CANCER INST · PI Marc Vidal · 2021 to 2026
$9.9M
Systematically mapping variant effects for cardiovascular genesR01HL164675 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI ASHLEY, EUAN A, RODEN, DAN M · 2022 to 2025
$8.1M
Comprehensive, context-aware, functional analysis of Cytochrome P450 variantsR01GM132162 · NIGMS · UNIVERSITY OF WASHINGTON · PI DUNHAM, MAITREYA J, FOWLER, DOUGLAS M · 2019 to 2022
$2.1M
NHGRI NIH HHS RM1 HG010461NHGRI NIH HHS UM1 HG011969NHGRI NIH HHS UM1 HG011989NHLBI NIH HHS R01 HL164675NIGMS NIH HHS R01 GM132162
6 · The paper itself

Abstract

Long read sequencing technologies, an attractive solution for many applications, often suffer from higher error rates. Alignment of multiple reads can improve base-calling accuracy, but some applications, e.g. sequencing mutagenized libraries where multiple distinct clones differ by one or few variants, require the use of barcodes or unique molecular identifiers. Unfortunately, sequencing errors can interfere with correct barcode identification, and a given barcode sequence may be linked to multiple independent clones within a given library. Here we focus on the target application of sequencing mutagenized libraries in the context of multiplexed assays of variant effects (MAVEs). MAVEs are increasingly used to create comprehensive genotype-phenotype maps that can aid clinical variant interpretation. Many MAVE methods use long-read sequencing of barcoded mutant libraries for accurate association of barcode with genotype. Existing long-read sequencing pipelines do not account for inaccurate sequencing or non-unique barcodes. Here, we describe Pacybara, which handles these issues by clustering long reads based on the similarities of (error-prone) barcodes while also detecting barcodes that have been associated with multiple genotypes. Pacybara also detects recombinant (chimeric) clones and reduces false positive indel calls. In three example applications, we show that Pacybara identifies and correctly resolves these issues.

Identifiers

PMID36865234
PMCPMC9980134
OpenAlexW4321607200

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.